Caplight Logo









Persephone Biosciences

Persephone Biosciences

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.persephonebiosciences.com

Last Round

Seed

Jul 19, 2022

Total Funding Raised

$15.32M

Company Overview

Persephone Biosciences, Inc. is a synthetic biology company that develops microbiome-based medicines and consumer health products. The company focuses on immuno-oncology and infant health, utilizing an end-to-end platform with artificial intelligence and omics techniques to analyze patient data and design microbial therapeutics. Persephone has established both a therapeutics division and a consumer health division, launching its first consumer product, a synbiotic for infants, based on its 'My Baby Biome' clinical study. The company's research also includes the ARGONAUT study, a large U.S. trial aimed at identifying biomarkers for cancer treatment and prevention by mapping the gut-immune axis. Founded in 2017, the company is venture-backed and has collaborations with major entities like Janssen Biotech and Ginkgo Bioworks.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

microbiome therapeuticsgut microbiomeAI drug discoverycompanion diagnosticsoncologyinfant gut healthCDxdrug discovery platformsynbioticsmulti-omics analysiscancer immunotherapyclinical studiespatient biobankprecision microbiomegut-immune axisbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Persephone Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Persephone Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 19, 2022
SeedFeb 19, 2021

Key People

Founding team and executive leadership

Stephanie Culler

Co-Founder And CEO

Founding Team

Persephone Biosciences Investors

Notable investors and investment history

Persephone Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Persephone Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Persephone Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range22
Year Founded2017
Last FundingJul 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.